Author:
Ostby Stuart A.,Daniel Saige,Kalogera Eleftheria,De Vitis Luigi,Fought Angela J.,McGree Michaela E.,Langstraat Carrie L.,Block Matthew S.
Reference14 articles.
1. Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology;Abu-Rustum;J. Natl. Compr. Canc. Netw.,2024
2. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: implications for clinical practice;Boer;Gynecol. Oncol.,2021
3. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis;D’Angelo;J. Clin. Oncol.,2017
4. Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006;Hamid;Br. J. Cancer,2018
5. Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma;Hou;Cancer,2017